5333

Novartis agreed to pay 29 million to settle multistate litigation alleging that it caused false claims to be submitted to state Medicaid programs by promoting the drug TOBI for uses not approved by the Food and Drug Administration. This was part of a larger 72.5 million settlement involving the federal government; ###-novartis-vaccines-and-diagnostics-inc-